Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Gut & Barrier Research
Wolverine Blend combines BPC-157 and TB-500 in a 10MG/10MG research format. It is studied in models of tissue response signaling, connective tissue biology, and cell migration. It also fits angiogenesis, inflammatory pathways, and cell research linked to repair.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkShipping batch BB04
Open the certificate matched to this shipping batch.
Verified test results
Each batch is analyzed by an independent third-party laboratory before release. The lots below were tested by Chromate and ILS Laboratories. Below is the report for lot BB04, summarized from the certificate the lab published.
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
Labeled10/10 mg
IdentityConfirmed: BPC-157 + TB-500
Measured20.94mg
TestedNov 11, 2026
View certificate →On recordLabeled20mg
IdentityConfirmed
Measured21.3mg
TestedAug 22, 2026
View certificate →On recordLabeled10/10mg
IdentityConfirmed
Measured21.14mg
TestedJun 10, 2026
View certificate →On recordLabeled1mg
IdentityConfirmed
Measured1mg
TestedJun 1, 2026
View certificate →Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Lyophilized research material
A two-component blend bringing BPC-157 and TB-500 into one research listing for tissue-response and cell-migration questions.
Wolverine contains BPC-157 and a component labeled TB-500. The catalog includes lyophilized and capsule formats; confirm each format and component amount separately.
The linked primary studies concern BPC-157 in tendon models and thymosin beta-4/actin-associated angiogenesis. They do not characterize this finished mixture.
Published findings describe the materials and conditions in the cited studies. Receptor or cell-pathway evidence does not establish safety or efficacy of this finished research product. Match the supplied identity and format to the current label and batch documentation.
Wolverine Blend combines BPC-157 and TB-500 in a 10MG/10MG research format. It is studied in models of tissue response signaling, connective tissue biology, and cell migration. It also fits angiogenesis, inflammatory pathways, and cell research linked to repair.
Disguised Alpha Wolverine Blend is made for researchers who expect more than a generic peptide blend. Each batch is reviewed through our internal quality assurance process. Third-party analytical testing supports that review. Our in-house team then ships each order directly.
Combines BPC-157 and TB-500 for research on tissue response and repair pathways that complement each other.
Wolverine Blend is built around two of the most well-known peptides in tissue response and recovery-focused research. BPC-157 is often studied in models of gastrointestinal biology and connective tissue response. It is also studied in inflammatory signaling and pathways linked to repair.
TB-500 is studied for its link to actin regulation, cell migration, and angiogenesis. It is also studied for vascular response and tissue remodeling. Together, the blend fits research models of soft tissue settings and connective tissue biology. It also fits cell repair signaling and inflammatory response.
Wolverine (BPC-157 / TB-500) research guide
Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.
Examined cell migration and FAK/paxillin signaling. The reported migration response should not be described as direct stimulation of cell proliferation.
Compared full-length thymosin beta-4 with a shorter region. Full-length thymosin beta-4 and a short TB-500 fragment are not interchangeable identities; check the lot-specific sequence.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
The listed milligrams refer to material per vial, not concentration or administration instructions. A prepared solution has its own concentration and stability requirements. Verify the exact selected option and shipping lot.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.
Two peptides in one lyophilized vial: 10MG BPC-157 and 10MG TB-500, as this page lists. BPC-157 is a synthetic 15-amino-acid peptide, a partial sequence of a protein described in human gastric juice. Analytical work on material sold as TB-500 identified an acetylated seven-residue fragment of thymosin beta-4, Ac-LKKTETQ.
Mostly one at a time, in cell and rodent models. Of the PubMed records that name both, one is a controlled experiment: a 2026 study that randomly assigned 32 rats with repaired Achilles tendons to control, BPC-157, TB-500 or both for four weeks, measuring load to failure and tendon histology. It reported no additive effect from the combination.
No. Drugs@FDA lists no product containing BPC-157 or thymosin beta-4, the parent protein of TB-500. A 2025 systematic review notes that BPC-157 lacks FDA approval, and a 2023 analysis of TB500 products sold online describes such products as lacking EMA or FDA approval for human or veterinary use.
Yes. The 2026 World Anti-Doping Agency Prohibited List names BPC-157 in class S0, non-approved substances, and "Thymosin-β4 and its derivatives e.g. TB-500" under S2.3, growth factors and growth factor modulators. Both classes are prohibited at all times.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy